We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXP:NYSEEagle Materials Inc Analysis

Data as of 2026-09-18 - not real-time

$176.82

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Eagle Materials Inc. is bearish at $176.82, with short-term averages lagging the long-term ones. Across the trailing 30 sessions it lost 16.3%. With RSI at 26.6 the momentum picture is oversold, alongside a bearish MACD signal. Price has been bracketed by support at $175.79 and resistance at $209.96.
The shares look fair at 13.9 times earnings, though no sector average was available for comparison. Analyst price targets sit 24.7% above the current price. Revenue is growing at 2.6% on a 17.3% profit margin. The 0.56% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.6%, a beta of 1.08 and a maximum drawdown of 28.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.

Top Market Events

Fintel reports that on September 9, 2026, Wells Fargo downgraded their outlook for Eagle Materials NYSE:EXP from...Thompson's sale represents 23% of his direct equity stake, executed as the stock trades near its weighted average sale...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 26.6 signals oversold conditions
  • Trading below the 200-day average of 209.59

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 26.6 signals oversold conditions
  • Trading below the 200-day average of 209.59

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +24.7% versus the current price
  • Profit margin of 17.3% is healthy
  • P/E ratio of 13.9

Key Metrics & Analysis

Financial Health

Revenue Growth2.60%
Profit Margin17.32%
P/E Ratio13.9
ROE27.03%
ROA9.23%
Debt/Equity120.75
P/B Ratio3.7
Op. Cash Flow$631.9M
Free Cash Flow$25.3M

Technical Analysis

TrendBearish
RSI26.6
Support$175.79
Resistance$209.96
MA 20$190.97
MA 50$201.98
MA 200$209.59
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Target Price$220.50
Upside/Downside24.70%
GradeFair
TypeBlend
Dividend Yield0.56%

Risk Assessment

Beta1.08
Volatility22.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.